University of California takes more action over AFib patents
The regents of the University of California, the institution’s governing body, has filed a complaint against US-based medical device company AtriCure for allegedly infringing patents covering a method of treating atrial fibrillation.
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
26 January 2026 The court found the board applied the wrong legal standard when evaluating Guardant Health’s obviousness challenge to a University of Washington DNA sequencing patent.
26 January 2026 The new recruit has a “stellar track record” of representing big tech in trade secret and patent litigation, and joins the firm’s newly opened San Francisco office.